ReviewFrontiers in oncology2022

Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate-Stage Hepatocellular Carcinoma, What Else Can We Do?

Jun Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.